Document is current
Any future updates will be listed below
-
Authors
Wendorff, Agnieszka A. http://orcid.org/0000-0002-4072-5271
Aidan Quinn, S.
Alvarez, Silvia
Brown, Jessie A. http://orcid.org/0000-0003-2396-5393
Biswas, Mayukh
Gunning, Thomas http://orcid.org/0000-0001-8116-8136
Palomero, Teresa
Ferrando, Adolfo A. http://orcid.org/0000-0002-6212-8574
-
Funding
Funding for this research was provided by:
Leukemia and Lymphoma Society
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA267168)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA206501, CA206501)
- License Information
-
More Information
Article History
Received: 9 January 2022
Accepted: 3 October 2022
First Online: 10 November 2022
Competing interests
: A.A.F., J.A.B. and S.A. are currently employed by Regeneron Pharmaceuticals. A.W. is currently employed by Calico. S.A.Q., M.B., T.G. and T.P. declare no competing interests.
